TG Therapeutics, Inc. ( TGTX) - Key Metrics
TGTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.35 | $0.16 | $0.14 | $0.14 |
| 2025Q3 | $1.11 | $2.69 | -$0.16 | -$0.16 |
| 2025Q2 | $0.96 | $0.19 | $0.05 | $0.05 |
| 2025Q1 | $0.82 | $0.03 | -$0.20 | -$0.20 |
TGTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 46.25 |
| 2025Q3 | ? | 3.36 |
| 2025Q2 | ? | 46.84 |
| 2025Q1 | ? | 285.75 |
TGTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.37% | ? |
| 2025Q4 | 0.46% | ? |
| 2025Q3 | -0.44% | ? |
| 2025Q2 | 0.14% | ? |
| 2025Q1 | -0.50% | ? |
TGTX
Price: $56.04
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.86 USD
P/E Ratio: 15.08
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.7 million
Ebitda: -31.6 millionMarket Capitalization: 8.9 billion